Abstract:Background: Acute kidney injury (AKI) is a frequent complication in patients with hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) and is associated with high rates of mortality. We aimed to estimate serum high mobility group protein 1 (HMGB1) levels in hepatitis B virus-related acute-on-chronic liver failure patients and analyze their clinical value in the development and outcomes of Acute kidney injury. Methods: A total of 251 consecutive patients with hepatitis B virus-related acute-on-chronic liver failure were enrolled in this retrospective study. Using the International Club of Ascites staging criteria of Acute kidney injury, 153 patients developed Acute kidney injury. The clinical data of patients were collected and serum levels of high mobility group protein 1 were measured by ELISA. All patients were followed up until death or for a minimum of 3 months. Early prediction and prognostic implications of high mobility group protein 1 in Hepatitis B Virus-Related Acute-on-Chronic Liver Failure Patients with Acute Kidney Injury were investigated in different cohorts, including a propensity score-matched ACLF cohort. Results: Among all individuals with hepatitis B virus-related acute-on-chronic liver failure, the incidence of Acute kidney injury was 61.0% (153/251). The patients who developed stage 2/3 Acute kidney injury showed the highest high mobility group protein 1 levels, followed by those who developed stage 1 Acute kidney injury, and those without Acute kidney injury showed the lowest high mobility group protein 1 levels. Moreover, high mobility group protein 1 levels were significantly higher in non-survivors than in survivors among hepatitis B virus-related acute-on-chronic liver failure patients with Acute kidney injury. Furthermore, analysis of the area under the receiver operating characteristic curve (AUROC) indicated that serum high mobility group protein 1 levels (pre-matching: AUC = 0.740; post-matching: AUC = 0.661) may be a potential predictive factor for Acute kidney injury development and that high mobility group protein 1 (AUC = 0.727) might be a reliable biomarker for prognosis in patients with Acute kidney injury. Conclusion: In patients with hepatitis B virus-related acute-on-chronic liver failure, Acute kidney injury is universal. Acute kidney injury and its stages negatively influence the 90-day transplant-free mortality rate. Serum high mobility group protein 1 levels can serve as a positive predictor of Acute kidney injury development, and high mobility group protein 1 might also be a prognostic biomarker for Acute kidney injury among hepatitis B virus-related acute-on-chronic liver failure patients.

Expression of Serum Hepatocyte Growth Factor in Patients with Acute Renal Failure

Clinical Significance of Growth Differentiation Factor-15 in Chronic Kidney Disease

Measurement of Serum Hepatocyte Growth Factor in Patients with Essential Hypertension

Expression of Hepatocyte Growth Factor and Transforming Growth Factor -βof Renal Tissues in Children with Nephropathy

Changes of Keratinocyte and Hepatocyte Growth Factor Contents in Bronchoalveolar Lavage Fluid and Serum in Patients with Acute Lung Injury

Serum Hepatocyte Growth Factor Concentration Correlates with Albuminuria in Individuals with Optimal Blood Pressure and Untreated Arterial Hypertension

Elevated serum cystatin C at continuous renal replacement therapy initiation predicts lack of renal recovery.

Hepatocyte Growth Factor-Induced Amelioration in Renal Interstitial Fibrosis is Associated with Reduced Expression of Alpha-Smooth Muscle Actin and Transforming Growth Factor-Beta1.

Urinary Epidermal Growth Factor Level as a Noninvasive Indicator of Tubular Repair in Patients with Acute Kidney Injury

Role of Hepatocyte Growth Factor in Renal Interstitial Fibrosis in Unilateral Ureteral Obstruction Rats

Elevated Serum Cystatin C at Continuous Renal Replacement Therapy Initiation Predicts Lack of Renal Recovery

Changes of serum cytokine levels in patients with acute on chronic liver failure treated by plasma exchange.

Acute Renal Allograft Rejection is Associated with Increased Levels of Vascular Endothelial Growth Factor in the Urine

Prognostic Significance of Plasma Hepatocyte Growth Factor in Sepsis

Effect of Hepatocyte Growth Factor on Human Renal Tubular Epithelial Cells Induced by High Glucose and Connective Tissue Growth Factor

Serum hepatocyte growth factor in gastric cancer and its clinical significance

Hepatocyte Growth Factor-Induced Amelioration in Chronic Renal Failure is Associated with Reduced Expression Ofα-Smooth Muscle Actin

Serum Insulin-Like Growth Factor 1 Level and Nutritional Assessment in Nondialytic Patients with Chronic Renal Failure.

Determination of HMGB1 in hepatitis B virus-related acute-on-chronic liver failure patients with acute kidney injury: Early prediction and prognostic implications

#5528 FIBROBLAST GROWTH FACTOR 21 PREDICTS ARTERIOVENOUS FISTULA FUNCTIONAL PATENCY LOSS AND MORTALITY IN PATIENTS UNDERGOING MAINTENANCE HEMODIALYSIS

Analysis Of Expression And Correlation Of Fibroblast Growth Factor 23 And Smooth Muscle Actin Alpha In Patients With Uremia In Internal Drteriovenous Fistula